Expression of Activating KIR2DS2 and KIR2DS4 Genes after Hematopoietic Cell Transplantation: Relevance to Cytomegalovirus Infection

Ghislaine Gallez‐Hawkins(City Of Hope National Medical Center), John A. Zaia(City Of Hope National Medical Center), Andrew Dagis(City of Hope), David Senitzer(City of Hope), Ryotaro Nakamura(City Of Hope National Medical Center), Ketevan Gendzekhadze(City Of Hope National Medical Center), Xiuli Li(Agricultural Genomics Institute at Shenzhen), Anne Franck(City of Hope), Lia Thao(City of Hope), Joycelynne Palmer(City of Hope), Arisa Oki(City of Hope), Stephen J. Forman(City Of Hope National Medical Center)
Transplantation and Cellular Therapy
April 30, 2011
10.1016/j.bbmt.2011.04.008
Cited by 37

Related Papers

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria
|New England Journal of Medicine|2006|1.3k
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754